Open science: The open clinical trials data journey
- PMID: 31347390
- DOI: 10.1177/1740774519865512
Open science: The open clinical trials data journey
Abstract
Open data sharing and access has the potential to promote transparency and reproducibility in research, contribute to education and training, and prompt innovative secondary research. Yet, there are many reasons why researchers don't share their data. These include, among others, time and resource constraints, patient data privacy issues, lack of access to appropriate funding, insufficient recognition of the data originators' contribution, and the concern that commercial or academic competitors may benefit from analyses based on shared data. Nevertheless, there is a positive interest within and across the research and patient communities to create shared data resources. In this perspective, we will try to highlight the spectrum of "openness" and "data access" that exists at present and highlight the strengths and weakness of current data access platforms, present current examples of data sharing platforms, and propose guidelines to revise current data sharing practices going forward.
Keywords: Open science; data sharing; individual participant data; transparency.
Comment in
-
Access to clinical trial data-Commentary.Clin Trials. 2019 Oct;16(5):552-554. doi: 10.1177/1740774519865528. Epub 2019 Jul 26. Clin Trials. 2019. PMID: 31347396 No abstract available.
Similar articles
-
The project data sphere initiative: accelerating cancer research by sharing data.Oncologist. 2015 May;20(5):464-e20. doi: 10.1634/theoncologist.2014-0431. Epub 2015 Apr 15. Oncologist. 2015. PMID: 25876994 Free PMC article.
-
Resource implications of preparing individual participant data from a clinical trial to share with external researchers.Trials. 2017 Jul 17;18(1):319. doi: 10.1186/s13063-017-2067-4. Trials. 2017. PMID: 28712359 Free PMC article.
-
Preparing individual patient data from clinical trials for sharing: the GlaxoSmithKline approach.Pharm Stat. 2014 May-Jun;13(3):179-83. doi: 10.1002/pst.1615. Epub 2014 Mar 25. Pharm Stat. 2014. PMID: 24668938
-
Transparency and objectivity in governance of clinical trials data sharing: Current practices and approaches.Clin Trials. 2019 Oct;16(5):547-551. doi: 10.1177/1740774519865517. Epub 2019 Jul 26. Clin Trials. 2019. PMID: 31347399 Review.
-
Characteristics of available studies and dissemination of research using major clinical data sharing platforms.Clin Trials. 2021 Dec;18(6):657-666. doi: 10.1177/17407745211038524. Epub 2021 Aug 18. Clin Trials. 2021. PMID: 34407656 Free PMC article. Review.
Cited by
-
Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials Methodology.J Natl Cancer Inst. 2022 Jun 13;114(6):819-828. doi: 10.1093/jnci/djab218. J Natl Cancer Inst. 2022. PMID: 34865086 Free PMC article. Review.
-
A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies.BMC Med. 2023 Oct 23;21(1):400. doi: 10.1186/s12916-023-03113-0. BMC Med. 2023. PMID: 37872545 Free PMC article.
-
Protocol for the development of a repository of individual participant data from randomised controlled trials conducted in adult care homes (the Virtual International Care Homes Trials Archive (VICHTA)).Trials. 2021 Feb 23;22(1):157. doi: 10.1186/s13063-021-05107-w. Trials. 2021. PMID: 33622396 Free PMC article.
-
Surrogacy Beyond Prognosis: The Importance of "Trial-Level" Surrogacy.Oncologist. 2022 Apr 5;27(4):266-271. doi: 10.1093/oncolo/oyac006. Oncologist. 2022. PMID: 35380717 Free PMC article. Review.
-
Open Science to Address COVID-19: Sharing Data to Make Our Research Investment Go Further.Ther Innov Regul Sci. 2021 May;55(3):558-560. doi: 10.1007/s43441-020-00250-z. Epub 2020 Dec 24. Ther Innov Regul Sci. 2021. PMID: 33368019 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
